Australia bets $1B on pricey hep C drugs in broad effort to eradicate the disease

Carly Helfand

Good news for Gilead Sciences and Bristol-Myers Squibb: 's federal government wants to eliminate hepatitis C in the country. And it plans to shell out $ 1 billion on the drugmakers' meds to do that.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS